Skip to content

Impact of Dairy Products on Postprandial Inflammation

The Impact of Dairy Products on Postprandial Inflammation in Obese Males

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01885416
Enrollment
21
Registered
2013-06-25
Start date
2013-01-31
Completion date
2013-11-30
Last updated
2013-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Nutritional Intervention, Obesity

Brief summary

The study will quantitatively evaluate the systemic, postprandial inflammatory and metabolic response to the ingestion of three different meals in obese subjects. The administered meals will differ in the proportion of dairy products. Postprandial response will be monitored during 6 hours after meal consumption.

Interventions

OTHERconsumption of test meal based on dairy products
OTHERconsumption of high fat test meal without dairy products
OTHERconsumption of high fat test meal with dairy products

Sponsors

Insel Gruppe AG, University Hospital Bern
CollaboratorOTHER
Agroscope Liebefeld-Posieux Research Station ALP
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
25 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* male * BMI ≥ 20 kg/m2 * age 25-55 y * informed consent

Exclusion criteria

* Physiological or psychological diseases * Allergies to food or intolerance to high-fat meal * Vegetarians * Chronic intake of drugs * Smokers * Diabetes mellitus Type I and II * Debilitating kidney diseases * Debilitating liver diseases * Clinically established coronary heart diseases * Ingestion of vitamins or dietary supplements during the course of the study

Design outcomes

Primary

MeasureTime frame
Inflammation markers in blood plasma (IL-6, TNF-alpha)0,6h

Secondary

MeasureTime frame
Biomarkers in blood (serum insulin, plasma glucose, GLP-1, lipids)0,1,2,4,6h
Endotoxin in blood serum0,6h

Other

MeasureTime frame
Blood cell transcriptome0,2,4,6h
blood serum metabolome0,2,4,6h

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026